{"@odata.context":"https://ghoapi.azureedge.net/api/$metadata#AMR_INFECT_ECOLI","value":[{"Id":1535930,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.4","NumericValue":56.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1586563,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69.2","NumericValue":69.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":10076460,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28","NumericValue":28.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9690838,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CIV","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75","NumericValue":75.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2037006,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"66.7","NumericValue":66.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4759069,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.1","NumericValue":13.090000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9113688,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"41.7","NumericValue":41.720000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":7258416,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TTO","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.8","NumericValue":27.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9685551,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.8","NumericValue":27.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6344592,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.2","NumericValue":46.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8464138,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.2","NumericValue":28.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":25205,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":10095685,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90","NumericValue":90.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":6579613,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"87.5","NumericValue":87.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":450385,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.7","NumericValue":6.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3896319,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.6","NumericValue":33.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8267650,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.1","NumericValue":77.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3661614,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KEN","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78","NumericValue":78.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8917273,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2316506,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.7","NumericValue":20.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7468026,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81","NumericValue":80.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6509818,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.5","NumericValue":12.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2189555,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.4","NumericValue":11.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8546854,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7391973,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11","NumericValue":10.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1002926,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBY","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.3","NumericValue":58.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8185234,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.1","NumericValue":73.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1123573,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24","NumericValue":23.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3008415,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"66.7","NumericValue":66.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4289995,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.7","NumericValue":7.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7201594,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.9","NumericValue":63.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2151613,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.5","NumericValue":12.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1009386,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.2","NumericValue":12.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3427156,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.2","NumericValue":15.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4112477,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.3","NumericValue":12.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":945928,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.9","NumericValue":5.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":241294,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.6","NumericValue":12.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2012025,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.5","NumericValue":11.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4987780,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.6","NumericValue":9.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1295206,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"87.8","NumericValue":87.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2354596,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"31.6","NumericValue":31.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2462677,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71","NumericValue":71.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4518629,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69.7","NumericValue":69.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8394880,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDG","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.5","NumericValue":40.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9266540,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"59.3","NumericValue":59.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2799078,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.7","NumericValue":27.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8483590,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.3","NumericValue":43.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2069278,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.8","NumericValue":50.850000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6694309,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.3","NumericValue":33.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7576394,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.6","NumericValue":25.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4379095,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.1","NumericValue":9.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3547996,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COL","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.6","NumericValue":28.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":44830,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.8","NumericValue":57.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6021993,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.7","NumericValue":46.720000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8540889,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.4","NumericValue":63.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":838195,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.5","NumericValue":21.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6174062,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4188917,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RWA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48","NumericValue":48.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2647125,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.9","NumericValue":50.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9422745,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.3","NumericValue":70.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7989040,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.1","NumericValue":8.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4969063,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.7","NumericValue":88.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2900969,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.8","NumericValue":81.820000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9886096,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.6","NumericValue":11.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":6878419,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63","NumericValue":63.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8509242,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.5","NumericValue":40.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2310739,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12","NumericValue":11.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":4100129,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.4","NumericValue":45.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1783749,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.5","NumericValue":50.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6967319,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30","NumericValue":30.040000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1777434,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDG","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9158882,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.2","NumericValue":28.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":2678862,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"87.8","NumericValue":87.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":501928,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.3","NumericValue":11.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9778367,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.5","NumericValue":17.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1764706,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.9","NumericValue":48.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9044937,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.5","NumericValue":60.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9708874,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.3","NumericValue":36.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":298966,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.2","NumericValue":17.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3180210,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.3","NumericValue":8.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3415141,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.3","NumericValue":16.350000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8477714,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.9","NumericValue":61.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":5527523,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.6","NumericValue":10.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4950364,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.3","NumericValue":57.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5584763,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.1","NumericValue":16.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2660101,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.1","NumericValue":85.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":10279015,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.8","NumericValue":18.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6726574,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.2","NumericValue":57.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7615086,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.6","NumericValue":81.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3637141,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3478725,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.1","NumericValue":27.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":724317,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19","NumericValue":18.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3231180,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63","NumericValue":62.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6586948,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.1","NumericValue":9.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3523161,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.4","NumericValue":9.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":10027040,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"32","NumericValue":32.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9114806,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2634864,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.5","NumericValue":77.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6199776,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5318537,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.2","NumericValue":17.190000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":451477,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.5","NumericValue":85.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3370971,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBR","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40","NumericValue":40.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6809303,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75.6","NumericValue":75.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2070003,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.1","NumericValue":37.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3922959,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6745819,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDV","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.4","NumericValue":70.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5432544,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.2","NumericValue":85.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6301402,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.3","NumericValue":6.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":432621,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.7","NumericValue":85.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":356532,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","TimeDimType":"YEAR","ParentLocationCode":null,"ParentLocation":null,"Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1739901,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.150000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":6022735,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.9","NumericValue":61.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":699259,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.3","NumericValue":15.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8002427,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.1","NumericValue":26.090000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5115783,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24","NumericValue":23.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2292350,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MAR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.9","NumericValue":35.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7666189,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.9","NumericValue":7.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8389516,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.7","NumericValue":54.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8931375,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.4","NumericValue":60.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9829792,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.7","NumericValue":52.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":90057,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.2","NumericValue":13.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3916877,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BTN","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.8","NumericValue":56.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7253617,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.2","NumericValue":52.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2895460,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"47.1","NumericValue":47.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1759144,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"34.4","NumericValue":34.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6784209,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75.1","NumericValue":75.110000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2305247,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.3","NumericValue":81.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2590888,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.5","NumericValue":88.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7951754,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"44.2","NumericValue":44.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":6803321,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDG","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.3","NumericValue":33.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1220224,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.8","NumericValue":78.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9668111,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.1","NumericValue":72.120000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3199960,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5528182,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HKG","TimeDimType":"YEAR","ParentLocationCode":null,"ParentLocation":null,"Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.1","NumericValue":30.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2355814,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"32.4","NumericValue":32.390000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9734818,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HKG","TimeDimType":"YEAR","ParentLocationCode":null,"ParentLocation":null,"Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.5","NumericValue":30.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3174574,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.6","NumericValue":77.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8231135,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50.9","NumericValue":50.850000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5243010,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.1","NumericValue":11.090000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3859913,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57","NumericValue":57.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":109334,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.1","NumericValue":80.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4881437,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.2","NumericValue":77.190000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2273688,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DZA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.4","NumericValue":55.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1556799,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.5","NumericValue":30.480000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4894128,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.8","NumericValue":60.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3663291,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.3","NumericValue":77.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9592199,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.1","NumericValue":70.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1353782,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"100","NumericValue":100.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4900451,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","TimeDimType":"YEAR","ParentLocationCode":null,"ParentLocation":null,"Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30","NumericValue":30.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9528808,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38","NumericValue":38.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":8136159,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.7","NumericValue":72.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1740436,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.8","NumericValue":58.840000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1835764,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.4","NumericValue":35.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1950129,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EST","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.6","NumericValue":11.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5281241,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.4","NumericValue":63.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4139495,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20","NumericValue":20.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6968464,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"91.7","NumericValue":91.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":534772,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.3","NumericValue":14.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9242509,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.9","NumericValue":28.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4374104,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.3","NumericValue":64.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2051611,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.8","NumericValue":30.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5585683,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.4","NumericValue":56.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6657853,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"84.9","NumericValue":84.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":693556,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.8","NumericValue":53.850000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4006151,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.5","NumericValue":10.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3124263,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TTO","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.3","NumericValue":26.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3359063,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65","NumericValue":65.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3853897,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.8","NumericValue":35.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2337065,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65.5","NumericValue":65.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8884588,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.1","NumericValue":6.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":10053157,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9134768,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NAM","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.180000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9567093,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.3","NumericValue":13.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1061890,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.8","NumericValue":14.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2819743,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EST","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12","NumericValue":12.010000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1417579,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COL","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.6","NumericValue":25.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":10185486,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.7","NumericValue":12.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8174639,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1081035,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.9","NumericValue":18.940000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9971623,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.6","NumericValue":17.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2236053,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.3","NumericValue":10.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":10166505,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.8","NumericValue":25.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9109576,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.3","NumericValue":10.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":852507,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18","NumericValue":18.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1887002,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.8","NumericValue":55.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4374475,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.4","NumericValue":52.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6480223,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBY","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.5","NumericValue":61.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":814461,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"89.6","NumericValue":89.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":10028235,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.6","NumericValue":43.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7476550,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.3","NumericValue":40.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":2337371,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.8","NumericValue":52.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7343185,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.1","NumericValue":18.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2781930,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.5","NumericValue":16.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3023143,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.1","NumericValue":9.070000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2553582,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.5","NumericValue":45.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7482916,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.1","NumericValue":54.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4387331,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.4","NumericValue":18.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":40325,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.3","NumericValue":13.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1918912,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.3","NumericValue":5.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6791392,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"68.7","NumericValue":68.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5262760,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"49.5","NumericValue":49.480000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2547292,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.1","NumericValue":71.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":268734,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CAN","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"23.4","NumericValue":23.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5250063,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.9","NumericValue":33.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9329438,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.3","NumericValue":21.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7870043,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MAR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.070000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4748858,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.9","NumericValue":12.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1703051,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":10128821,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.4","NumericValue":80.390000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9630879,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.9","NumericValue":61.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1722124,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.5","NumericValue":22.470000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9965656,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.6","NumericValue":5.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":5681482,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.4","NumericValue":37.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3245369,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"YEM","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.4","NumericValue":86.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":618043,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.2","NumericValue":21.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1125936,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDV","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63","NumericValue":62.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":503728,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.9","NumericValue":90.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4476308,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"83.5","NumericValue":83.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1392753,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.3","NumericValue":58.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6455214,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78","NumericValue":77.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":161069,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24.9","NumericValue":24.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":7343520,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.4","NumericValue":48.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7343522,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.3","NumericValue":17.300000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8175148,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.2","NumericValue":86.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9027678,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.3","NumericValue":58.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1341954,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.5","NumericValue":46.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":10079218,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.6","NumericValue":56.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2369651,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ETH","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"84.2","NumericValue":84.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2998207,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.7","NumericValue":39.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3213812,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.8","NumericValue":33.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5415033,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NAM","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.5","NumericValue":37.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6785434,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.1","NumericValue":5.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8631894,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24.5","NumericValue":24.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4305198,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.7","NumericValue":30.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5167999,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.6","NumericValue":7.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3607076,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.1","NumericValue":20.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5611883,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.3","NumericValue":70.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1532500,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.1","NumericValue":37.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7388220,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.8","NumericValue":81.820000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6271282,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.3","NumericValue":11.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4686202,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.6","NumericValue":63.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6353831,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8777749,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":6043207,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EST","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.9","NumericValue":7.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2516010,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"41","NumericValue":41.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5022120,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.6","NumericValue":55.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6652507,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.8","NumericValue":72.800000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5389809,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"31.1","NumericValue":31.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6322141,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.7","NumericValue":71.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":10129273,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SYR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.6","NumericValue":78.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1272455,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"76.5","NumericValue":76.470000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6811147,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40","NumericValue":40.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1151758,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"79.2","NumericValue":79.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6151079,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARG","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.8","NumericValue":19.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8048454,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.7","NumericValue":8.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8181698,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.6","NumericValue":36.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":10154855,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.5","NumericValue":5.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2192520,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80","NumericValue":80.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5669278,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.7","NumericValue":12.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9205603,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.7","NumericValue":58.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1075693,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.1","NumericValue":36.110000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":320298,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.3","NumericValue":6.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7394904,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1444041,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24.6","NumericValue":24.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3525241,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.1","NumericValue":8.130000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5796272,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.2","NumericValue":27.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6214578,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"75","NumericValue":75.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6163878,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COD","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69","NumericValue":68.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4337438,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.1","NumericValue":20.120000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1431418,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.6","NumericValue":6.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6309764,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KEN","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.2","NumericValue":77.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8435662,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.6","NumericValue":19.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":5783641,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.2","NumericValue":73.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2211794,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.8","NumericValue":80.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1564671,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.8","NumericValue":6.750000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8270900,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.4","NumericValue":77.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":250669,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36.4","NumericValue":36.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":9072913,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40","NumericValue":40.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8860591,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":10035634,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.2","NumericValue":10.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2929006,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.7","NumericValue":10.750000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7687150,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.7","NumericValue":28.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1977020,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70","NumericValue":70.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6925522,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.5","NumericValue":16.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3791919,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"QAT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"42.3","NumericValue":42.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6348016,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53","NumericValue":52.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4109252,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.6","NumericValue":9.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":3259011,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.4","NumericValue":16.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2745050,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":4655120,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.7","NumericValue":11.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8854419,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.8","NumericValue":77.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4413777,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.5","NumericValue":61.540000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3176478,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NOR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"5.7","NumericValue":5.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9831797,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.6","NumericValue":51.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3671401,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17","NumericValue":17.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":498336,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6037562,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"44","NumericValue":44.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7769580,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.4","NumericValue":20.390000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3094099,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"56.5","NumericValue":56.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3100440,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.8","NumericValue":58.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8106144,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.7","NumericValue":6.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":5200546,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MUS","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"49.6","NumericValue":49.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9256911,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7","NumericValue":6.990000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2732418,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PER","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"76.7","NumericValue":76.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4762690,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.440000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1869256,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.8","NumericValue":25.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6887632,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5568301,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.4","NumericValue":90.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":498401,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.4","NumericValue":13.350000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2231180,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"77.8","NumericValue":77.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9142755,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9","NumericValue":8.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":2523111,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"24","NumericValue":24.010000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7465183,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.4","NumericValue":15.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5460344,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.8","NumericValue":26.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":10237820,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GHA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.6","NumericValue":90.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7592318,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.7","NumericValue":15.650000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":384272,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"93.1","NumericValue":93.100000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9954291,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13.4","NumericValue":13.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":10193385,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.7","NumericValue":22.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":1107953,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"93.5","NumericValue":93.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8927255,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CIV","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90","NumericValue":90.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1139759,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.7","NumericValue":21.730000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3919087,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.7","NumericValue":73.720000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":974788,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.320000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3741459,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IND","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.8","NumericValue":86.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":10225256,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.9","NumericValue":15.890000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8835689,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PSE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"47.4","NumericValue":47.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3589098,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18","NumericValue":18.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":384435,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.150000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9219031,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.2","NumericValue":78.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":10054974,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.3","NumericValue":18.300000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1165289,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.2","NumericValue":20.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7205166,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.2","NumericValue":43.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":10212629,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IDN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.9","NumericValue":71.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":2796172,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZMB","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.5","NumericValue":51.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":6494541,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5574944,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.4","NumericValue":73.440000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":5416192,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GEO","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.7","NumericValue":43.650000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8873819,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"82.3","NumericValue":82.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3335646,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","TimeDimType":"YEAR","ParentLocationCode":null,"ParentLocation":null,"Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.5","NumericValue":38.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5264294,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SDN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"66.7","NumericValue":66.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7478183,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.780000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7681413,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.2","NumericValue":9.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9973408,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.2","NumericValue":6.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8201795,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"23.8","NumericValue":23.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9463990,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"26.5","NumericValue":26.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1000437,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.3","NumericValue":20.340000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1197268,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.4","NumericValue":14.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1742639,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.8","NumericValue":38.840000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":663932,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"97.9","NumericValue":97.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7167277,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.8","NumericValue":10.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":835324,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"40.6","NumericValue":40.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9282897,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"57.1","NumericValue":57.140000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3158269,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.3","NumericValue":52.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5816322,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRQ","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"94.9","NumericValue":94.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3120061,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"67","NumericValue":67.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8036925,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.4","NumericValue":7.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":4807654,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEN","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"76.9","NumericValue":76.880000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6621898,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TZA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.1","NumericValue":70.150000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8297124,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.8","NumericValue":53.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8842323,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.7","NumericValue":38.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3925905,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KEN","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"63.6","NumericValue":63.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7681639,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MAR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"44.7","NumericValue":44.740000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3456507,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.5","NumericValue":64.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":175398,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.3","NumericValue":37.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":511743,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30","NumericValue":29.980000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9331248,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.3","NumericValue":8.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4046606,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.2","NumericValue":37.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2758527,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.2","NumericValue":18.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8544565,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.5","NumericValue":12.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8861546,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.7","NumericValue":16.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9344004,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.6","NumericValue":38.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5594461,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.9","NumericValue":22.940000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2466620,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SWE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.6","NumericValue":7.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":4909398,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BTN","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.9","NumericValue":53.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":10093679,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"13","NumericValue":13.040000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9588459,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.5","NumericValue":17.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2688854,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JOR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.4","NumericValue":60.420000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3012610,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"36","NumericValue":36.030000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3748527,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.9","NumericValue":39.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3773918,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.5","NumericValue":25.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":880132,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SGP","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.7","NumericValue":28.690000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":10130774,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21.9","NumericValue":21.930000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":994557,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CZE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"14.2","NumericValue":14.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":2504906,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.9","NumericValue":35.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9451840,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65.3","NumericValue":65.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":5334614,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.4","NumericValue":10.440000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1312175,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LKA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"67.7","NumericValue":67.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":3247455,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TLS","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.4","NumericValue":30.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7954861,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"65.3","NumericValue":65.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4833558,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"86.2","NumericValue":86.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":6520726,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"HRV","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.6","NumericValue":15.580000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5569379,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"23.5","NumericValue":23.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1032735,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11.9","NumericValue":11.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5918367,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60","NumericValue":60.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5201694,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.3","NumericValue":6.310000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8399158,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.3","NumericValue":19.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6844371,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BTN","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.6","NumericValue":80.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":442416,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"EGY","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"89.4","NumericValue":89.410000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9350733,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.3","NumericValue":52.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7916824,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ISL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.8","NumericValue":9.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4193038,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.5","NumericValue":78.520000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":5848735,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.2","NumericValue":8.160000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6266866,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"58.5","NumericValue":58.470000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":9395196,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PAK","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.9","NumericValue":88.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3380977,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"79.2","NumericValue":79.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1927719,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GRC","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.9","NumericValue":22.860000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9782432,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.9","NumericValue":43.890000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1756132,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"OMN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"78.9","NumericValue":78.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5214554,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.7","NumericValue":6.690000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5493373,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.7","NumericValue":37.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2517996,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LUX","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.9","NumericValue":10.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":17417,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"6.6","NumericValue":6.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8868500,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.2","NumericValue":10.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8012384,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.5","NumericValue":48.530000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":5087609,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.6","NumericValue":15.600000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":2118210,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.8","NumericValue":7.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":5347639,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.2","NumericValue":16.170000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7028755,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.8","NumericValue":19.790000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":4066363,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"60.9","NumericValue":60.870000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6876351,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.1","NumericValue":46.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":8640493,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.6","NumericValue":39.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":721961,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"59.1","NumericValue":59.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2080193,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"32.5","NumericValue":32.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":182581,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ISL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12","NumericValue":12.020000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":3926798,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"YEM","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90.4","NumericValue":90.360000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":5106886,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.3","NumericValue":51.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":2899039,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"XKX","TimeDimType":"YEAR","ParentLocationCode":null,"ParentLocation":null,"Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"37.5","NumericValue":37.500000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2327481,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.3","NumericValue":20.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7790209,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"61.8","NumericValue":61.760000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4085573,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"TUN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"25.5","NumericValue":25.460000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":9169654,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71.1","NumericValue":71.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9344897,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CMR","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70","NumericValue":70.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":4548760,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.4","NumericValue":30.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":1889978,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.3","NumericValue":35.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":2302572,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MYS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.4","NumericValue":27.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":8431342,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COL","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"30.8","NumericValue":30.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":3565380,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUS","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"12.4","NumericValue":12.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1528619,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BGD","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"90","NumericValue":90.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":6058216,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PHL","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.6","NumericValue":35.620000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":8387029,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"70.6","NumericValue":70.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1293785,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FIN","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.6","NumericValue":7.590000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8992204,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"88.2","NumericValue":88.240000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":7193942,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NPL","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73","NumericValue":72.970000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":5830263,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.9","NumericValue":8.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8799246,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LBN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"55.3","NumericValue":55.330000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":2391421,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BIH","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"22.3","NumericValue":22.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1408279,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NLD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.2","NumericValue":7.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":1490745,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"46.4","NumericValue":46.380000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1661983,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.9","NumericValue":52.940000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":5671690,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KOR","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"38.9","NumericValue":38.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":4339699,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.7","NumericValue":10.680000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":7105212,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DNK","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"7.3","NumericValue":7.270000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":10207992,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MOZ","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.3","NumericValue":64.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":1122520,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MDA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.1","NumericValue":64.060000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":443225,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COD","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"72.5","NumericValue":72.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9478251,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"RUS","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.6","NumericValue":64.630000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9383279,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"IRN","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"69.2","NumericValue":69.230000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":9802187,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"FRA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"8.9","NumericValue":8.920000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5900332,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53.8","NumericValue":53.810000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3984415,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"UKR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.5","NumericValue":54.550000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":7295797,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MWI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"84.2","NumericValue":84.210000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2702774,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LTU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2016,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.7","NumericValue":9.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2016","TimeDimensionBegin":"2016-01-01T00:00:00+01:00","TimeDimensionEnd":"2016-12-31T00:00:00+01:00"},{"Id":1839626,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CMR","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"96.3","NumericValue":96.300000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":3584637,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BHR","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"50","NumericValue":50.000000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":6896096,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"85.7","NumericValue":85.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":3660861,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.6","NumericValue":80.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":747934,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MMR","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"81.3","NumericValue":81.250000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":9151157,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"48.1","NumericValue":48.070000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":805198,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.6","NumericValue":20.640000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6185324,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BFA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.8","NumericValue":80.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":1503664,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"20.4","NumericValue":20.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":7162577,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LVA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.9","NumericValue":18.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6471007,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BRA","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"15.9","NumericValue":15.900000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":8438161,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"53","NumericValue":52.960000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":887750,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.4","NumericValue":9.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":1103665,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"COD","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.1","NumericValue":73.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":1827003,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"28.7","NumericValue":28.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6699582,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"AUT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.4","NumericValue":9.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":760725,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ARE","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.7","NumericValue":51.670000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5767269,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLI","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.8","NumericValue":45.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6864510,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MLT","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"16.4","NumericValue":16.370000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6414084,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"52.6","NumericValue":52.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9732724,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"27.7","NumericValue":27.700000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":437324,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"JPN","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"21","NumericValue":20.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":9577390,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CYP","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"19.6","NumericValue":19.570000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":3369407,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"NGA","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"80.8","NumericValue":80.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":6090538,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"51.2","NumericValue":51.220000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5317050,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"GBR","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.3","NumericValue":10.260000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":913510,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"64.3","NumericValue":64.290000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":6350664,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ZAF","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.4","NumericValue":35.430000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":8641351,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CAN","TimeDimType":"YEAR","ParentLocationCode":"AMR","ParentLocation":"Americas","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"17.4","NumericValue":17.450000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":6471362,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KHM","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.5","NumericValue":73.510000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":8279992,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"THA","TimeDimType":"YEAR","ParentLocationCode":"SEAR","ParentLocation":"South-East Asia","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"39.4","NumericValue":39.400000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":1890843,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"MKD","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"71","NumericValue":71.050000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":9107303,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"KWT","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"43.7","NumericValue":43.660000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":5805594,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"9.6","NumericValue":9.560000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":6065380,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CHE","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"11","NumericValue":10.950000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":7118529,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"DEU","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2020,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"10.2","NumericValue":10.200000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2020","TimeDimensionBegin":"2020-01-01T00:00:00+01:00","TimeDimensionEnd":"2020-12-31T00:00:00+01:00"},{"Id":4023107,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"BEN","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2022,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.1","NumericValue":73.080000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2022","TimeDimensionBegin":"2022-01-01T00:00:00+01:00","TimeDimensionEnd":"2022-12-31T00:00:00+01:00"},{"Id":9240456,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"LAO","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2017,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"45.3","NumericValue":45.280000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2017","TimeDimensionBegin":"2017-01-01T00:00:00+01:00","TimeDimensionEnd":"2017-12-31T00:00:00+01:00"},{"Id":4378434,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"ITA","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2019,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"33.6","NumericValue":33.610000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2019","TimeDimensionBegin":"2019-01-01T00:00:00+01:00","TimeDimensionEnd":"2019-12-31T00:00:00+01:00"},{"Id":7683640,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"POL","TimeDimType":"YEAR","ParentLocationCode":"EUR","ParentLocation":"Europe","Dim1Type":null,"Dim1":null,"TimeDim":2021,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"18.8","NumericValue":18.830000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2021","TimeDimensionBegin":"2021-01-01T00:00:00+01:00","TimeDimensionEnd":"2021-12-31T00:00:00+01:00"},{"Id":8019963,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"SAU","TimeDimType":"YEAR","ParentLocationCode":"EMR","ParentLocation":"Eastern Mediterranean","Dim1Type":null,"Dim1":null,"TimeDim":2018,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"54.8","NumericValue":54.770000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-05-07T13:40:20.167+02:00","TimeDimensionValue":"2018","TimeDimensionBegin":"2018-01-01T00:00:00+01:00","TimeDimensionEnd":"2018-12-31T00:00:00+01:00"},{"Id":6763444,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"PNG","TimeDimType":"YEAR","ParentLocationCode":"WPR","ParentLocation":"Western Pacific","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"35.7","NumericValue":35.710000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"},{"Id":2303555,"IndicatorCode":"AMR_INFECT_ECOLI","SpatialDimType":"COUNTRY","SpatialDim":"CMR","TimeDimType":"YEAR","ParentLocationCode":"AFR","ParentLocation":"Africa","Dim1Type":null,"Dim1":null,"TimeDim":2023,"Dim2Type":null,"Dim2":null,"Dim3Type":null,"Dim3":null,"DataSourceDimType":null,"DataSourceDim":null,"Value":"73.9","NumericValue":73.910000000,"Low":null,"High":null,"Comments":"Percentage of bloodstream infection due to  Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested. AMR Surveillance National Coordinating Center","Date":"2025-10-22T14:28:29.95+02:00","TimeDimensionValue":"2023","TimeDimensionBegin":"2023-01-01T00:00:00+01:00","TimeDimensionEnd":"2023-12-31T00:00:00+01:00"}]}